The Ontario Health Coalition has called on the Health Minister to halt Quest/LifeLabs from transferring Ontario patients' lab tests to U.S. reference labs following Quest's acquisition of LifeLabs in 2024. The coalition highlights risks including patient privacy breaches, reduced test quality, delayed results, and financial losses for Ontario hospitals. They argue that restoring lab testing to local public hospitals would improve care quality, speed, and cost-efficiency while keeping control within Canada. The coalition also demands transparency by requesting all contracts between the Ontario government and Quest/LifeLabs.
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
Several stocks experienced significant declines today driven by company-specific events. SANUWAVE Health's shares dropped 39.21% despite strong revenue guidance, Twin Vee Powercats fell 30.95% amid a legal investigation, and Gorilla Technology declin...
The stock market saw significant gains driven by corporate announcements and high trading volumes, particularly in battery technology, electric vehicles, and green energy sectors. Electrovaya surged 49.05% after announcing a commercial deal with Amaz...
An Akamai Technologies executive sold 3,100 shares as the company shifts focus from its declining content delivery network business to high-growth cloud infrastructure and cybersecurity services. This strategic pivot is supported by a $1.8 billion, s...
Taiwan Semiconductor Manufacturing Company (TSMC) is set to report earnings on July 16, 2026, with analysts expecting revenue around $39.85 billion, up significantly from last year due to high demand for AI chips. Earnings per share are forecasted at...
